Paper35978433
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts.
Wang Y and 14 others. J Hematol Oncol, 2022. Cited by 207 papers, by iCite.
Cite this record
ConductScience Library. Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts. Papers, record 35978433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35978433
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Programmed Cell Death 1 Receptor | Major topic |
| B7-H1 Antigen | |
| CTLA-4 Antigen | |
| Humans | |
| Immune Checkpoint Proteins | |
| Immunologic Factors | |
| Immunotherapy |
Source PubMed
References184
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24357146 | Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8(+) T cells. | Cancer Immunol Immunother | 2014 | https://conductscience.org/library/papers/24357146 | PubMed |
| 2 | 28187290 | Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. | Cell | 2017 | https://conductscience.org/library/papers/28187290 | PubMed |
| 3 | 34986285 | Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma. | N Engl J Med | 2022 | https://conductscience.org/library/papers/34986285 | PubMed |
| 4 | 18332220 | Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. | J Cell Biol | 2008 | https://conductscience.org/library/papers/18332220 | PubMed |
| 5 | 19047103 | Preclinical characterization of SGN-70, a humanized antibody directed against CD70. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/19047103 | PubMed |
| 6 | 12821648 | Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. | J Cell Biol | 2003 | https://conductscience.org/library/papers/12821648 | PubMed |
| 7 | 29472691 | A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy. | Cell Res | 2018 | https://conductscience.org/library/papers/29472691 | PubMed |
| 8 | 32938950 | An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA. | Sci Rep | 2020 | https://conductscience.org/library/papers/32938950 | PubMed |
| 9 | 30034942 | Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells. | Am J Cancer Res | 2018 | https://conductscience.org/library/papers/30034942 | PubMed |
| 10 | 32047024 | CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. | Cancer Immunol Res | 2020 | https://conductscience.org/library/papers/32047024 | PubMed |
| 11 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 12 | 29899446 | Induction and transcriptional regulation of the co-inhibitory gene module in T cells. | Nature | 2018 | https://conductscience.org/library/papers/29899446 | PubMed |
| 13 | 29339377 | Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. | Cancer Immunol Res | 2018 | https://conductscience.org/library/papers/29339377 | PubMed |
| 14 | 30478397 | Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation. | Nat Immunol | 2019 | https://conductscience.org/library/papers/30478397 | PubMed |
| 15 | 33485464 | First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. | Lancet | 2021 | https://conductscience.org/library/papers/33485464 | PubMed |
| 16 | 8921170 | Cloning of murine LAG-3 by magnetic bead bound homologous probes and PCR (gene-capture PCR). | Anal Biochem | 1996 | https://conductscience.org/library/papers/8921170 | PubMed |
| 17 | 12445278 | Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. | Immunol Rev | 2002 | https://conductscience.org/library/papers/12445278 | PubMed |
| 18 | 21064155 | B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells. | Hepatology | 2010 | https://conductscience.org/library/papers/21064155 | PubMed |
| 19 | 27079802 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27079802 | PubMed |
| 20 | 11592063 | LAP, a lymphocyte activation gene-3 (LAG-3)-associated protein that binds to a repeated EP motif in the intracellular region of LAG-3, may participate in the down-regulation of the CD3/TCR activation pathway. | Eur J Immunol | 2001 | https://conductscience.org/library/papers/11592063 | PubMed |
Cited by149
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889351 | Molecular profiling and prognostic significance of gastric cancer subtypes based on extracellular vesicle-related characteristics. | Front Oncol | 2026 | https://conductscience.org/library/papers/42889351 | PubMed |
| 42829648 | VISTA Confers Renal Protection in Murine Hemorrhage/Infection-Induced Acute Kidney Injury: Associations with Altered NGAL and HMGB1 Expression. | Immunotargets Ther | 2026 | https://conductscience.org/library/papers/42829648 | PubMed |
| 42626346 | New progress and clinical research translation of immune checkpoint inhibitors in systemic therapy of gallbladder cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42626346 | PubMed |
| 42376474 | Raman spectroscopy combined with multiple technologies for label-free identification of immune cells: An overview. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/42376474 | PubMed |
| 42321301 | Glucocorticoid and mitophagy signaling-based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42321301 | PubMed |
| 42212138 | Dynamic changes in peripheral blood lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in metastatic osteosarcoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42212138 | PubMed |
| 42176073 | Breakthroughs in HBV-related HCC Therapy: The Unmatched Potential of Immune Checkpoint Inhibitors. | Curr Treat Options Oncol | 2026 | https://conductscience.org/library/papers/42176073 | PubMed |
| 42099621 | From immune exclusion to exhaustion: tumor microenvironment drives therapy response. | Front Immunol | 2026 | https://conductscience.org/library/papers/42099621 | PubMed |
| 42075555 | Comprehensive Overview of Gastric Cancer Immunohistochemistry: Key Biomarkers, Advanced Detection Methods, and Perspectives. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42075555 | PubMed |
| 41899513 | Tumor Microenvironment and Immune Response Against Wilms Tumor: Evasion Mechanisms and Implications for Immunotherapeutic Approaches. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899513 | PubMed |
| 41852018 | Advances in immunotherapy for cytomegalovirus infection following allogeneic hematopoietic stem cell transplantation. | Immunotherapy | 2026 | https://conductscience.org/library/papers/41852018 | PubMed |
| 41827731 | TIGIT Blockade Potentiates the Anti-Leukemic Activity of Exercise-Mobilized Donor Lymphocytes and Expanded γδ T-Cells. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41827731 | PubMed |
| 41811823 | Next-Generation Immune Checkpoints and Tumor Microenvironment Modulation in Cancer Immunotherapy. | J Immunol Res | 2026 | https://conductscience.org/library/papers/41811823 | PubMed |
| 41673236 | Social determinants of health in studies using PROMs to assess toxicities associated with immune checkpoint inhibitor treatment: a systematic review. | Support Care Cancer | 2026 | https://conductscience.org/library/papers/41673236 | PubMed |
| 41613111 | The role of immune checkpoint molecules in cancers. | Front Immunol | 2025 | https://conductscience.org/library/papers/41613111 | PubMed |
| 41562147 | Pharmacovigilance Insights Into Immune Checkpoint Inhibitor-Induced Risk of Paraneoplastic Syndrome: A Large-Scale Real World Study. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/41562147 | PubMed |
| 41556173 | Ultrasound-mediated targeted micro/nanobubbles: breaking new boundaries in precision tumor therapy. | Int J Surg | 2026 | https://conductscience.org/library/papers/41556173 | PubMed |
| 41486149 | Post-translational modifications of immune checkpoints: molecular mechanisms, tumor microenvironment remodeling, and therapeutic implications. | J Biomed Sci | 2026 | https://conductscience.org/library/papers/41486149 | PubMed |
| 41383500 | A CD47 antibody with minimized erythrocyte and thrombocyte toxicities. | Front Oncol | 2025 | https://conductscience.org/library/papers/41383500 | PubMed |
| 41340912 | Ruthenium coordinated nanohybrids modulate tumor microenvironment and potentiate amplified phototherapy augmented immunotherapy of hypoxic tumor. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41340912 | PubMed |
Genes109
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35978433
GET https://conductscience.org/api/papers/v1/35978433/references?page=2